Chadwick Jeremy G bought KYMR
April 14, 2026 · Form 4 insider transaction
Chadwick Jeremy G bought 785 shares of Kymera Therapeutics, Inc. at $43.50 per share, a transaction worth $34.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
785
Price
$43.50
Total value
$34.1K
InsiderChadwick Jeremy G
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 14, 2026
Filing dateApril 16, 2026
Shares owned after66,453
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.